$8,60
▲ +$0,02
(+0,23%)
Vol. 32K
5
Punteggio di Qualità
fail
Ricavi ✗
Utile netto ✗
>IPO ✗
Cap. mercato
$129.6M
ROE
-4,6%
Margine
-2,3%
D/E
0,00
Beta
1,35
52W
$8–$13
Consenso Wall Street
10 analisti · Apr 20262
Acquisto forte
4
Compra
4
Mantieni
0
Vendi
0
Vendita forte
60,0%
Rating Compra
Grafico dei Prezzi
Utili
Tasso di battuta: 60,0%| Trimestre | EPS Stimato | EPS Effettivo | Sorpresa |
|---|---|---|---|
| Dic 2025 | $0,04 | $0,07 | +$0,03 |
| Set 2025 | $0,00 | $0,02 | +$0,02 |
| Giu 2025 | $-0,02 | $-0,06 | $-0,04 |
| Mar 2025 | $0,00 | $-0,03 | $-0,03 |
Ricavi e utili trimestrali
| Trimestre | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… | 2025-1… |
|---|---|---|---|---|---|---|
| Ricavi | — | -$38.3M | $13.1M | $13.3M | $13.4M | $15.2M |
| Utile netto | — | -$2.7M | $968K | $93K | $855K | $991K |
Trend fondamentali
| Metrica | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -24.5% | -24.5% | -24.5% | -24.5% | -4.6% | -4.6% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | 0.7% | -6.1% | -6.1% | -6.1% | -2.3% | -2.3% |
| Gross Margin | 79.1% | 82.1% | 82.1% | 82.1% | 78.4% | 78.4% |
| D/E Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 1.80 | 1.80 | 1.80 | 1.80 | 1.83 | 1.83 |
Rapporti chiave
ROA (TTM)
-1,3%
P/S (TTM)
1,65
P/B
8,9
EPS (TTM)
$-0,07
CF/Share
$0,65
Crescita ricavi 3A
-13,4%
52W High
$13,47
52W Low
$7,50
$7,50
Intervallo 52 settimane
$13,47
Salute finanziaria
Flusso di cassa libero
$2.5M
Debito netto
-$21.6M
Liquidità
$23.6M
Debito totale
$2.0M
Aggiornato al Dic 31, 2025
Як JYNT виглядає на тлі конкурентів у Health Care?
Група порівняння: Micro-cap Health Care (All) · 241 компаній
Оцінка JYNT vs аналоги Health Care
P/E
—
▼
0%
sotto
peer
(30,7)
vs Peer
vs Settore
Sottovalutato
P/S
1,7
▼
36%
sotto
peer
(2,6)
vs Peer
vs Settore
Più costoso
P/B
8,9
▲
220%
sopra
peer
(2,8)
vs Peer
vs Settore
Sopravvalutato
Дивідендна дохідність
—
▼
0%
sotto
peer
(0,7%)
vs Peer
vs Settore
Rendimento basso
Прибутковість JYNT vs аналоги Health Care
ROE
-4,6%
▲
88%
sopra
peer
(-38,5%)
vs Peer
vs Settore
Sotto media
Net margin
-2,3%
▲
91%
sopra
peer
(-24,7%)
vs Peer
vs Settore
Sotto media
Валова маржа
78,4%
▲
48%
sopra
peer
(52,9%)
vs Peer
vs Settore
Top livello
ROA
-1,3%
▲
94%
sopra
peer
(-21,2%)
vs Peer
vs Settore
Sotto media
Фінансове здоровʼя JYNT vs аналоги Health Care
D/E ratio
0,0
▼
100%
sotto
peer
(19,3)
vs Peer
vs Settore
Debito basso
Поточна ліквідність
1,8
▼
15%
sotto
peer
(2,2)
vs Peer
vs Settore
In linea
Beta
1,4
▲
29%
sopra
peer
(1,1)
vs Peer
vs Settore
Più volatile
Радар фундаменталів JYNT
JYNT
Mediana peer
Industria
JYNT прибутковість vs борг
Розмір бульбашки = капіталізація · X = чиста маржа · Y = D/E ratio
JYNT vs аналоги: ключові метрики
Attività insider
NeutralAcquisti
0
Vendite
0
RAZDAN SANJIV KUMAR
Chief Executive Officer · Mar 09
73484 shs
BOWMAN SCOTT JUSTIN
Chief Financial Officer · Mar 09
28301 shs
JOBSON CHARLES E
Beneficial Owner of more than… · Feb 12
15397 shs
JOBSON CHARLES E
Beneficial Owner of more than… · Feb 11
448 shs
JOBSON CHARLES E
Beneficial Owner of more than… · Gen 26
17478 shs
JOBSON CHARLES E
Beneficial Owner of more than… · Gen 06
5240 shs
Ultimo 90 giorni
Principali azionisti
Top 5: 52,35%Bandera Partners LLC
27,90%
$33.2M
Vanguard Group Inc
7,09%
$8.4M
Blackrock Inc.
6,84%
$8.2M
Skylands Capital, LLC
6,31%
$7.5M
JCP Investment Management, …
4,21%
$5.0M
Aggiornato al Dic 31, 2025
Ultime notizie
Nessuna notizia correlata ancora